Results 31 to 40 of about 5,168 (136)

Overlap between EBV‐positive diffuse large B‐cell lymphoma, NOS, in a young patient and angioimmunoblastic T‐cell lymphoma: A diagnostic pitfall

Clinical Case Reports, 2021
There may be significant histopathologic overlap between EBV‐positive DLBCL, NOS, and other diagnoses including angioimmunoblastic T‐cell lymphoma (AITL).
Chae Hwa Kim, Taban Ghaffaripour, Yi Zhou, Jennifer R. Chapman   +3 more
doaj   +1 more source

Not your typical morbilliform rash: Angioimmunoblastic T‐cell lymphoma

Clinical Case Reports, 2021
Angioimmunoblastic T‐cell lymphoma (AITL) is a rare but aggressive lymphoma that commonly presents with skin involvement, often morphologically similar to viral or drug‐induced morbilliform eruptions. Morbilliform rashes with systemic symptoms of unclear
Wendi Bao, Kendall L. Buchanan, Loretta S. Davis   +2 more
doaj   +1 more source

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore, Madeleine Neildez, Adèle de Masson, Maxime Battistella, Marie Tauber, Saskia Ingen‐Housz‐Oro, Catherine Droitcourt, Delphine Staumont‐Sallé, Marie Beylot‐Barry   +8 more
wiley   +1 more source

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn, Alexandre O. Gérard, Maëlys Labat, Zoe Apalla, Wouter van Binsbergen, Dimitra Koumaki, Valerian Rivet, Frederic Dezoteux, Damien Giacchero, Michael R. Ardern‐Jones, Kara Heelan, Jesse P. Hirner, Ander Mayor, Mariette Labots, Markus V. Starink, Conny J. van der Laken, Vincent Sibaud, Yannick S. Elshot   +17 more
wiley   +1 more source

Composite Angioimmunoblastic T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma Presenting with Distributive Shock

Hematology Reports, 2023
Diffuse large B-cell lymphoma (DLBCL) and angioimmunoblastic T-cell lymphoma (AITL) are two subtypes of non-Hodgkin lymphoma (NHL). The simultaneous occurrence of DLBCL and AITL in a composite lymphoma is very rare, and there are no established treatment
Nisha Hariharan, Alisha Kabadi, Michelle Don, Mazen Odish, Benjamin Heyman   +4 more
doaj   +1 more source

The Atypical and Suspicious for Malignancy Categories of the WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Review of their Diagnostic Utility, Limitations, and Clinical Impact

Diagnostic Cytopathology, Volume 54, Issue 6, Page 449-460, June 2026.
ABSTRACT Background Fine‐needle aspiration biopsy (FNAB) is the preferred first‐line diagnostic tool for evaluating lymphadenopathy due to its minimally invasive nature and cost‐effectiveness. However, cytopathological interpretation of lymph node FNAB remains challenging because of the wide morphological spectrum of lymphoid lesions.
Immacolata Cozzolino, Mats Ehinger, Oscar Lin, Elisabetta Maffei, Pio Zeppa, Andrew S. Field   +5 more
wiley   +1 more source

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma

Zhongliu Fangzhi Yanjiu, 2020
Objective To analyze the safety and efficacy of pemetrexed-based chemotherapy on patients with mid-elderly non-Hodgkin's lymphoma. Methods We retrospectively reviewed the clinical data of patients with non-Hodgkin's lymphoma treated with pemetrexed-based
WEN Tingyu, GUI Lin, JIN Jun, ZHANG Wei, WANG Ting, SHI Yuankai, LIU Peng   +6 more
doaj   +1 more source

Hypercalcemia as a rare presentation of angioimmunoblastic T cell lymphoma: a case report

Journal of Medical Case Reports, 2018
Background Angioimmunoblastic T cell lymphoma is a rare malignancy, accounting for only 2% of all non-Hodgkin lymphomas, first described in the 1970s and subsequently accepted as a distinct entity in the current World Health Organization classification ...
Sana Chams, Inaya Hajj Hussein, Skye El Sayegh, Nour Chams, Khalid Zakaria   +4 more
doaj   +1 more source

The first report of colonic involvement of angioimmunoblastic T-cell lymphoma

The Turkish Journal of Gastroenterology, 2020
Cite this article as: Turan İ, Özsan N, Doğanavşargil B, Arslan Davulcu E, Bülbül H. The first report of colonic involvement of angioimmunoblastic T-cell lymphoma. Turk J Gastroenterol 2020; 5: 413-4.
İlker Turan, Nazan Özsan, Başak Doğanavşargil, Eren Arslan Davulcu, Hale Bülbül   +4 more
doaj   +1 more source

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma

Acta Dermato-Venereologica, 2021
is missing (Short communication)
Shoko Hattori, Fumi Miyagawa, Keiko Fukuda, Kohei Ogawa, Hideo Asada   +4 more
doaj   +1 more source